Skip to main content
. 2022 Apr 27;13(6):1175–1185. doi: 10.1007/s13300-022-01253-9

Table 1.

Meta-analysis results for change in HbA1c by timepoint and type of diabetes

Timepoints (months) Age group Type of diabetes Number of trials Change in HbA1c (%) Lower CL Upper CL Q I2 P value τ2
3–4 Adults T1DM 16 − 0.53 − 0.69 − 0.38 181.1 91.7 < 0.0001 0.06574
3–4 Adults T2DM 5 − 0.45 − 0.57 − 0.33 9.9 59.5 0.0427 0.00000
4.5–7.5 Adults T1DM 23 − 0.42 − 0.58 − 0.27 336.5 93.5 < 0.0001 0.1030
4.5–7.5 Adults T2DM 9 − 0.59 − 0.80 − 0.39 71.9 88.9 < 0.0001 0.06313

There was substantial heterogeneity between trials, with I2 above 75% in T1DM at each timepoint. For T2DM, I2 was also above 75% at 4.5–7.5 months, with other timepoints comprising 5 or fewer trials

T1DM, type 1 diabetes; T2DM, type 2 diabetes